Discover 625 paid clinical trials in Arkansas. Search by city or condition to find a research study near you that matches your needs across various therapeutic areas.
Arkansas offers a variety of research opportunities for both healthy volunteers interested in paid clinical studies and individuals seeking trials for specific health conditions. Major research centers in Little Rock, Fayetteville, and Fort Smith are actively recruiting participants, providing access to advanced treatments and innovative medical care.
Filter
1
Filter results
Results: 625
Active & Responsive
Candida Therapeutic Vaccine in Head and Neck Cancer Patients to Reduce Recurrence
for
Squamous Cell Carcinoma of Head and Neck
Location: Mineola NY, New York NY, Little Rock AR,
Sponsor: University of Arkansas
Sex: All
Age: 18 - 70+
Code: NCT05952934
Phase 2, Recruiting
Active & Responsive
RENAISSANCE 2: SPN-817 Phase 2, Double-Blind, Placebo-Controlled Study in Adults With Focal Onset Seizures
for
Focal Onset Seizures
Location: New Haven CT, Neptune City NJ, New York NY,
Sponsor: Supernus Pharmaceuticals, Inc.
Sex: All
Age: 18 - 70
Code: NCT06798896
Phase 2, Recruiting
Active & Responsive
Venetoclax in Children With Relapsed Acute Myeloid Leukemia (AML)
for
Acute Myeloid Leukemia
Location: Halifax, Boston MA, New Haven CT, Queens NY,
Sponsor: PedAL BCU, LLC
Sex: All
Age: 0 - 21
Code: NCT05183035
Phase 3, Recruiting
Active & Responsive
JAGUAR Trial: ObJective Analysis to GaUge EVAR Outcomes Through Randomization
for
AAA, AAA - Abdominal Aortic Aneurysm
Location: Boston MA, Staten Island NY, New York NY, Newark NJ,
Sponsor: Endologix
Sex: All
Age: 21+
Code: NCT05064540
Recruiting
Active & Responsive
Study of NRTX-1001 Neural Cell Therapy in Drug-Resistant Unilateral Mesial Temporal Lobe Epilepsy (EPIC (EPIlepsy Cell Therapy))
for
Mesial Temporal Lobe Epilepsy
Location: Boston MA, Lebanon NH, Great Neck NY, New York NY,
Sponsor: Neurona Therapeutics
Sex: All
Age: 18 - 70+
Code: NCT05135091
Phase 3, Recruiting
Interested in new trials?
Get alerts for new trials in your area by subscribing now
Active & Responsive
Study of Oral Food Challenge Biomarkers (SAFER)
for
Allergy
Location: New York NY, Baltimore MD, Chapel Hill NC, Ann Arbor MI,
Sponsor: National Institute of Allergy and Infectious Diseases (NIAID)
Sex: All
Age: 1 - 17
Code: NCT07279467
Recruiting
Active & Responsive
A 52-week Study of Remibrutinib in IgE-mediated Food Allergy
Forward Treatment of Attention Deficit and Hyperactivity Using Solriamfetol (FOCUS-3)
for
ADHD
Location: Worcester MA, Springfield MA, Staten Island NY,
Sponsor: Axsome Therapeutics, Inc.
Sex: All
Age: 12 - 17
Code: NCT07717892
Phase 3, Recruiting
Active & Responsive
Forward Treatment of Attention Deficit and Hyperactivity Using Solriamfetol (FOCUS-2)
for
ADHD
Location: Worcester MA, Springfield MA, Staten Island NY,
Sponsor: Axsome Therapeutics, Inc.
Sex: All
Age: 6 - 11
Code: NCT07717879
Phase 3, Recruiting
Active & Responsive
An Open-label, Single-arm Study of Prophylaxis for Datopotamab Deruxtecan (Dato-DXd) -Related Stomatitis in Eligible Patients With Metastatic or Inoperable Locally Recurrent Breast Cancer or Locally Advanced or Metastatic Epidermal Growth Factor Receptor-Mutated Non-small Cell Lung Cancer.
for
Stomatitis
Location: Wynnewood PA, East Syracuse NY, Fairfax VA, Wilson NC,
Sponsor: AstraZeneca
Sex: All
Age: 18+
Code: NCT07357597
Phase 4, Recruiting
Active & Responsive
A Study of Targeted Post-Surgery Radiation Therapy for Non-Small Cell Lung Cancer With Remaining Lymph Node Cancer After Treatment
A Trial to Evaluate Ovarian Suppression Following Subcutaneous ZOLADEX 10.8 mg in Premenopausal Women With Early-stage and Advanced HR+ Breast Cancer
for
Advanced Breast Cancer, Early Breast Cancer
Location: Westbury NY, The Bronx NY, New York NY, Amsterdam NY,
Sponsor: TerSera Therapeutics LLC
Sex: Female
Age: 18 - 55
Code: NCT07310420
Phase 1, Recruiting
Active & Responsive
A Study to Assess the Tolerability of Ianalumab (VAY736) With Investigator's Choice Thrombopoietin Receptor Agonist (IC TPO-RA) in Patients With Primary Immune Thrombocytopenia (ITP)
for
Primary Immune Thrombocytopenia (ITP),
Location: New Haven CT, Stamford CT, The Bronx NY, Summit NJ,
Sponsor: Novartis Pharmaceuticals
Sex: All
Age: 18+
Code: NCT07421167
Phase 2, Recruiting
Active & Responsive
PK, Safety and Preliminary Efficacy Study of Montelukast in Critically Ill Infants With Developing Bronchopulmonary Dysplasia
Location: Scarborough ME, Boston MA, New Haven CT,
Sponsor: Black Diamond Therapeutics, Inc.
Sex: All
Age: 18+
Code: NCT07326566
Phase 2, Recruiting
Active & Responsive
Target Trial Emulation for Pharmacologic Treatment of Neonatal Opioid Withdrawal Syndrome
for
Neonatal Opioid Withdrawal Syndrome
Location: Philadelphia PA, Tampa FL, Lexington KY,
Sponsor: HELP for NOWS Consortium
Sex: All
Age: 0+
Code: NCT07278375
Recruiting
Active & Responsive
A Study to Assess the Safety, Tolerability, Efficacy, Pharmacokinetics, and Immunogenicity of Intravenous Administration of ARGX-119 in Pediatric Participants Aged 5 to Less Than 18 Years With Spinal Muscular Atrophy
for
Spinal Muscular Atrophy (SMA)
Location: Boston MA, Hartford CT, New York NY, Hillsborough NC,